FDA Hits Aesica Over Quality Controls, Record-Keeping Post author:Sam Post published:April 19, 2017 Post category:Drug Industry Daily The FDA has cited contract manufacturer Aesica for quality and record-keeping problems. Source: Drug Industry Daily You Might Also Like FDA Will Soon Decide on Potentially Groundbreaking BMS Drug for Advanced Melanoma January 6, 2022 Australia Hikes GMP Clearance Fees May 29, 2019 Brexit Taking Early Effect on EMA October 31, 2017